SearcharxivSearch

arXiv subjects

Beate Diehl

Publications and source records attributed to Beate Diehl.

At least 19 recordsLinked to original sources

Seizure duration is associated with multiple timescales in interictal iEEG band power

Background Seizure severity can change from one seizure to the next within individual people with epilepsy. It is unclear if and how seizure severity is modulated over longer timescales. Characterising seizure severity variability over time could lead to tailored treatments. In this study, we test if continuously-recorded interictal intracranial EEG (iEEG) features encapsulate signatures of such modulations. Methods We analysed 20 subjects with iEEG recordings of at least one day. We identified cycles on timescales of hours to days embedded in long-term iEEG band power and associated them with seizure severity, which we approximated using seizure duration. In order to quantify these associations, we created linear-circular statistical models of seizure duration that incorporated different band power cycles within each subject. Findings In most subjects, seizure duration was weakly to moderately correlated with individual band power cycles. Combinations of multiple band power cycles significantly explained most of the variability in seizure duration. Specifically, we found 70% of the models had a higher than 60% adjusted $R^2$ across all subjects. From these models, around 80% were deemed to be above chance-level (p-value < 0.05) based on permutation tests. Models included cycles of ultradian, circadian and slower timescales in a subject-specific manner. Interpretation These results suggest that seizure severity, as measured by seizure duration, may be modulated over timescales of minutes to days by subject-specific cycles in interictal iEEG signal properties. These cycles likely serve as markers of seizure modulating processes. Future work can investigate biological drivers of these detected fluctuations and may inform novel treatment strategies that minimise seizure severity.

q-bio.NC

Dual mechanism of Anti-Seizure Medications in controlling seizure activity

Background: Anti-seizure medications (ASMs) can reduce seizure duration, but their precise modes of action are unclear. Specifically, it is unknown whether ASMs shorten seizures by simply compressing existing seizure activity into a shorter time frame or by selectively suppressing certain seizure activity patterns. Methods: We analysed intracranial EEG (iEEG) recordings of 457 seizures from 28 people with epilepsy undergoing ASM tapering. Beyond measuring seizure occurrence and duration, we categorized distinct seizure activity patterns (states) based on spatial and frequency power characteristics and related these to different ASM levels. Results: We found that reducing ASM levels led to increased seizure frequency (r = 0.87, p < 0.001) and longer seizure duration ($\beta$ = -0.033, p < 0.001), consistent with prior research. Further analysis revealed two distinct mechanisms in which seizures became prolonged: Emergence of new seizure patterns - In approx. 40% of patients, ASM tapering unmasked additional seizure activity states, and seizures containing these 'taper-emergent states' were substantially longer (r = 0.49, p < 0.001). Prolongation of existing seizure patterns - Even in seizures without taper-emergent states, lower ASM levels still resulted in approx. 12-224% longer durations depending on the ASM dosage and tapering ($\beta$ = -0.049, p < 0.001). Conclusion: ASMs influence seizures through two mechanisms: they (i) suppress specific seizure activity patterns (states) in an all-or-nothing fashion and (ii) curtail the duration of other seizure patterns. These findings highlight the complex role of ASMs in seizure modulation and could inform personalized dosing strategies for epilepsy management. These findings may also have implications in understanding the effects of ASMs on cognition and mood.

q-bio.NC

Anti-seizure medication load is not correlated with early termination of seizure spread

Objective: Anti-seizure medications (ASMs) are the mainstay of treatment for epilepsy, yet their effect on seizure spread is not fully understood. Higher ASM doses have been associated with shorter and less severe seizures. We aimed to test if this effect was due to limiting seizure spread through early termination of otherwise unchanged seizures. Methods: We retrospectively examined intracranial EEG (iEEG) recordings in 15 subjects who underwent ASM tapering during pre-surgical monitoring. We estimated ASM plasma concentrations based on pharmaco-kinetic modeling. In each subject, we identified seizures that followed the same onset and initial spread patterns, but some seizures terminated early (truncated seizures), and other seizures continued to spread (continuing seizures). We first compared seizure duration to ASM concentration for all seizures and the subset of seizures included in truncated-continuing pairs. Then we compared durations of the matched truncated and continuing seizures. Finally, we compared ASM concentrations at the times of truncated seizures and continuing seizures. Results: Seizure durations were found to be significantly longer at lower ASM concentrations. Continuing seizures were significantly longer in duration than matched truncated seizures. We found no substantial difference between ASM concentrations when truncated vs. continuing seizures occurred. Significance: The lack of difference between ASM concentrations at the time of truncated vs. continuing seizures implies a separate mechanism for shortening the duration of seizures beyond stopping the spread pathways early. Additionally, the mechanism causing seizures to be truncated remains unclear. Further research is needed to understand how ASM may modulate seizure duration and severity.

q-bio.NC

Anti-seizure medication tapering correlates with daytime delta band power reduction in the cortex

Anti-seizure medications (ASMs) are the primary treatment for epilepsy, yet medication tapering effects have not been investigated in a dose, region, and time-dependent manner, despite their potential impact on research and clinical practice. We examined over 3000 hours of intracranial EEG recordings in 32 subjects during long-term monitoring, of which 22 underwent concurrent ASM tapering. We estimated ASM plasma levels based on known pharmaco-kinetics of all the major ASM types. We found an overall decrease in the power of delta band activity around the period of maximum medication withdrawal in most (80%) subjects, independent of their epilepsy type or medication combination. The degree of withdrawal correlated positively with the magnitude of delta power decrease. This dose-dependent effect was evident across all recorded cortical regions during daytime; but not in sub-cortical regions, or during night time. We found no evidence of a differential effect in seizure onset, spiking, or pathological brain regions. The finding of decreased delta band power during ASM tapering agrees with previous literature. Our observed dose-dependent effect indicates that monitoring ASM levels in cortical regions may be feasible for applications such as medication reminder systems, or closed-loop ASM delivery systems. ASMs are also used in other neurological and psychiatric conditions, making our findings relevant to a general neuroscience and neurology audience.

q-bio.NC

Multi-centre normative brain mapping of intracranial EEG lifespan patterns in the human brain

Background: Understanding healthy human brain function is crucial to identify and map pathological tissue within it. Whilst previous studies have mapped intracranial EEG (icEEG) from non-epileptogenic brain regions, these maps do not consider the effects of age and sex. Further, most existing work on icEEG has often suffered from a small sample size due to the modality's invasive nature. Here, we substantially increase the subject sample size compared to existing literature, to create a multi-centre, normative map of brain activity which additionally considers the effects of age, sex and recording hospital. Methods: Using interictal icEEG recordings from n = 502 subjects originating from 15 centres, we constructed a normative map of non-pathological brain activity by regressing age and sex on relative band power in five frequency bands, whilst accounting for the hospital effect. Results: Recording hospital significantly impacted normative icEEG maps in all frequency bands, and age was a more influential predictor of band power than sex. The age effect varied by frequency band, but no spatial patterns were observed at the region-specific level. Certainty about regression coefficients was also frequency band specific and moderately impacted by sample size. Conclusion: The concept of a normative map is well-established in neuroscience research and particularly relevant to the icEEG modality, which does not allow healthy control baselines. Our key results regarding the hospital site and age effect guide future work utilising normative maps in icEEG.

q-bio.NC

Alpha rhythm slowing in temporal epilepsy across Scalp EEG and MEG

EEG slowing is reported in various neurological disorders including Alzheimer's, Parkinson's and Epilepsy. Here, we investigate alpha rhythm slowing in individuals with refractory temporal lobe epilepsy (TLE), compared to healthy controls, using scalp electroencephalography (EEG) and magnetoencephalography (MEG). We retrospectively analysed data from 17,(46) healthy controls and 22,(24) individuals with TLE who underwent scalp EEG and (MEG) recordings as part of presurgical evaluation. Resting-state, eyes-closed recordings were source reconstructed using the standardized low-resolution brain electrographic tomography (sLORETA) method. We extracted low (slow) 6-9 Hz and high (fast) 10-11 Hz alpha relative band power and calculated the alpha power ratio by dividing low (slow) alpha by high (fast) alpha. This ratio was computed for all brain regions in all individuals. Alpha oscillations were slower in individuals with TLE than controls (p<0.05). This effect was present in both the ipsilateral and contralateral hemispheres, and across widespread brain regions. Alpha slowing in TLE was found in both EEG and MEG recordings. We interpret greater low (slow)-alpha as greater deviation from health.

q-bio.NC

Incomplete resection of the icEEG seizure onset zone is not associated with post-surgical outcomes

Delineation of seizure onset regions from EEG is important for effective surgical workup. However, it is unknown if their complete resection is required for seizure freedom, or in other words, if post-surgical seizure recurrence is due to incomplete removal of the seizure onset regions. Retrospective analysis of icEEG recordings from 63 subjects (735 seizures) identified seizure onset regions through visual inspection and algorithmic delineation. We analysed resection of onset regions and correlated this with post-surgical seizure control. Most subjects had over half of onset regions resected (70.7% and 60.5% of subjects for visual and algorithmic methods, respectively). In investigating spatial extent of onset or resection, and presence of diffuse onsets, we found no substantial evidence of association with post-surgical seizure control (all AUC<0.7, p>0.05). Seizure onset regions tends to be at least partially resected, however a less complete resection is not associated with worse post-surgical outcome. We conclude that seizure recurrence after epilepsy surgery is not necessarily a result of failing to completely resect the seizure onset zone, as defined by icEEG. Other network mechanisms must be involved, which are not limited to seizure onset regions alone.

q-bio.NC

Complementary structural and functional abnormalities to localise epileptogenic tissue

When investigating suitability for surgery, people with drug-refractory focal epilepsy may have intracranial EEG (iEEG) electrodes implanted to localise seizure onset. Diffusion-weighted magnetic resonance imaging (dMRI) may be acquired to identify key white matter tracts for surgical avoidance. Here, we investigate whether structural connectivity abnormalities, inferred from dMRI, may be used in conjunction with functional iEEG abnormalities to aid localisation and resection of the epileptogenic zone (EZ), and improve surgical outcomes in epilepsy. We retrospectively investigated data from 43 patients with epilepsy who had surgery following iEEG. Twenty five patients (58%) were free from disabling seizures (ILAE 1 or 2) at one year. For all patients, T1-weighted and diffusion-weighted MRIs were acquired prior to iEEG implantation. Interictal iEEG functional, and dMRI structural connectivity abnormalities were quantified by comparison to a normative map and healthy controls respectively. First, we explored whether the resection of maximal (dMRI and iEEG) abnormalities related to improved surgical outcomes. Second, we investigated whether the modalities provided complementary information for improved prediction of surgical outcome. Third, we suggest how dMRI abnormalities may be useful to inform the placement of iEEG electrodes as part of the pre-surgical evaluation using a patient case study. Seizure freedom was 15 times more likely in those patients with resection of maximal dMRI and iEEG abnormalities (p=0.008). Both modalities were separately able to distinguish patient outcome groups and when combined, a decision tree correctly separated 36 out of 43 (84%) patients based on surgical outcome. Structural dMRI could be used in pre-surgical evaluations, particularly when localisation of the EZ is uncertain, to inform personalised iEEG implantation and resection.

q-bio.NC

Diminished circadian and ultradian rhythms of human brain activity in pathological tissue in vivo

Chronobiological rhythms, such as the circadian rhythm, have long been linked to neurological disorders, but it is currently unknown how pathological processes affect the expression of biological rhythms in the brain. Here, we use the unique opportunity of long-term, continuous intracranially recorded EEG from 38 patients (totalling 6338 hours) to delineate circadian (daily) and ultradian (minute to hourly) rhythms in different brain regions. We show that functional circadian and ultradian rhythms are diminished in pathological tissue, independent of regional variations. We further demonstrate that these diminished rhythms are persistent in time, regardless of load or occurrence of pathological events. These findings provide evidence that brain pathology is functionally associated with persistently diminished chronobiological rhythms in vivo in humans, independent of regional variations or pathological events. Future work interacting with, and restoring, these modulatory chronobiological rhythms may allow for novel therapies.

q-bio.NC

Interictal MEG abnormalities to guide intracranial electrode implantation and predict surgical outcome

Intracranial EEG (iEEG) is the gold standard technique for epileptogenic zone (EZ) localisation, but requires a hypothesis of which tissue is epileptogenic, guided by qualitative analysis of seizure semiology and other imaging modalities such as magnetoencephalography (MEG). We hypothesised that if quantifiable MEG band power abnormalities were sampled by iEEG, then patients' post-resection seizure outcome were better. Thirty-two individuals with neocortical epilepsy underwent MEG and iEEG recordings as part of pre-surgical evaluation. Interictal MEG band power abnormalities were derived using 70 healthy controls as a normative baseline. MEG abnormality maps were compared to electrode implantation, with the spatial overlap of iEEG electrodes and MEG abnormalities recorded. Finally, we assessed if the implantation of electrodes in abnormal tissue, and resection of the strongest abnormalities determined by MEG and iEEG explained surgical outcome. Intracranial electrodes were implanted in brain tissue with the most abnormal MEG findings in individuals that were seizure-free post-resection (T=3.9, p=0.003). The overlap between MEG abnormalities and iEEG electrodes distinguished outcome groups moderately well (AUC=0.68). In isolation, the resection of the strongest MEG and iEEG abnormalities separated surgical outcome groups well (AUC=0.71, AUC=0.74 respectively). A model incorporating all three features separated outcome groups best (AUC=0.80). Intracranial EEG is a key tool to delineate the EZ and help render patients seizure-free after resection. We showed that data-driven abnormalities derived from interictal MEG recordings have clinical value and may help guide electrode placement in individuals with neocortical epilepsy. Finally, our predictive model of post-operative seizure-freedom, which leverages both MEG and iEEG recordings, may aid patient counselling of expected outcome.

q-bio.NC

Normative brain mapping using scalp EEG and potential clinical application

A normative electrographic activity map could be a powerful resource to understand normal brain function and identify abnormal activity. Here, we present a normative brain map using scalp EEG in terms of relative band power. In this exploratory study we investigate its temporal stability, its similarity to other imaging modalities, and explore a potential clinical application. We constructed scalp EEG normative maps of brain dynamics from 17 healthy controls using source-localised resting-state scalp recordings. We then correlated these maps with those acquired from MEG and intracranial EEG to investigate their similarity. Lastly, we use the normative maps to lateralise abnormal regions in epilepsy. Spatial patterns of band powers were broadly consistent with previous literature and stable across recordings. Scalp EEG normative maps were most similar to other modalities in the alpha band, and relatively similar across most bands. Towards a clinical application in epilepsy, we found abnormal temporal regions ipsilateral to the epileptogenic hemisphere. Scalp EEG relative band power normative maps are spatially stable across time, in keeping with MEG and intracranial EEG results. Normative mapping is feasible and may be potentially clinically useful in epilepsy. Future studies with larger sample sizes and high-density EEG are now required for validation.

q-bio.NC

Temporal stability of intracranial EEG abnormality maps for localising epileptogenic tissue

Objective: Identifying abnormalities in interictal intracranial EEG, by comparing patient data to a normative map, has shown promise for the localisation of epileptogenic tissue and prediction of outcome. The approach typically uses short interictal segments of around one minute. However, the temporal stability of findings has not been established. Methods: Here, we generated a normative map of iEEG in non-pathological brain tissue from 249 patients. We computed regional band power abnormalities in a separate cohort of 39 patients for the duration of their monitoring period (0.92-8.62 days of iEEG data, mean 4.58 days per patient, over 4,800 hours recording). To assess the localising value of band power abnormality, we computed DRS - a measure of how different the surgically resected and spared tissue were in terms of band power abnormalities - over time. Results: In each patient, band power abnormality was relatively consistent over time. The median DRS of the entire recording period separated seizure free (ILAE = 1) and not seizure free (ILAE > 1) patients well (AUC = 0.69). This effect was similar interictally (AUC = 0.69) and peri-ictally (AUC = 0.71). Significance: Our results suggest that band power abnormality DRS, as a predictor of outcomes from epilepsy surgery, is a relatively robust metric over time. These findings add further support for abnormality mapping of neurophysiology data during presurgical evaluation.

q-bio.NC

A library of quantitative markers of seizure severity

Purpose: Understanding fluctuations of seizure severity within individuals is important for defining treatment outcomes and response to therapy, as well as developing novel treatments for epilepsy. Current methods for grading seizure severity rely on qualitative interpretations from patients and clinicians. Quantitative measures of seizure severity would complement existing approaches, for EEG monitoring, outcome monitoring, and seizure prediction. Therefore, we developed a library of quantitative electroencephalographic (EEG) markers that assess the spread and intensity of abnormal electrical activity during and after seizures. Methods: We analysed intracranial EEG (iEEG) recordings of 1056 seizures from 63 patients. For each seizure, we computed 16 markers of seizure severity that capture the signal magnitude, spread, duration, and post-ictal suppression of seizures. Results: Quantitative EEG markers of seizure severity distinguished focal vs. subclinical and focal vs. FTBTC seizures across patients. In individual patients, 71% had a moderate to large difference (ranksum r > 0.3) between focal and subclinical seizures in three or more markers. Circadian and longer-term changes in severity were found for 67% and 53% of patients, respectively. Conclusion: We demonstrate the feasibility of using quantitative iEEG markers to measure seizure severity. Our quantitative markers distinguish between seizure types and are therefore sensitive to established qualitative differences in seizure severity. Our results also suggest that seizure severity is modulated over different timescales. We envisage that our proposed seizure severity library will be expanded and updated in collaboration with the epilepsy research community to include more measures and modalities.

q-bio.NC

Focal and Connectomic Mapping of Transiently Disrupted Brain Function

The distributed nature of the neural substrate, and the difficulty of establishing necessity from correlative data, combine to render the mapping of brain function a far harder task than it seems. Methods capable of combining connective anatomical information with focal disruption of function are needed to disambiguate local from global neural dependence, and critical from merely coincidental activity. Here we present a comprehensive framework for focal and connective spatial inference based on sparse disruptive data, and demonstrate its application in the context of transient direct electrical stimulation of the human medial frontal wall during the pre-surgical evaluation of patients with focal epilepsy. Our framework formalizes voxel-wise mass-univariate inference on sparsely sampled data within the statistical parametric mapping framework, encompassing the analysis of distributed maps defined by any criterion of connectivity. Applied to the medial frontal wall, this transient dysconnectome approach reveals marked discrepancies between local and distributed associations of major categories of motor and sensory behaviour, revealing differentiation by remote connectivity to which purely local analysis is blind. Our framework enables disruptive mapping of the human brain based on sparsely sampled data with minimal spatial assumptions, good statistical efficiency, flexible model formulation, and explicit comparison of local and distributed effects.

q-bio.NC

Intracranial EEG structure-function coupling predicts surgical outcomes in focal epilepsy

Alterations to structural and functional brain networks have been reported across many neurological conditions. However, the relationship between structure and function -- their coupling -- is relatively unexplored, particularly in the context of an intervention. Epilepsy surgery alters the brain structure and networks to control the functional abnormality of seizures. Given that surgery is a structural modification aiming to alter the function, we hypothesized that stronger structure-function coupling preoperatively is associated with a greater chance of post-operative seizure control. We constructed structural and functional brain networks in 39 subjects with medication-resistant focal epilepsy using data from intracranial EEG (pre-surgery), structural MRI (pre-and post-surgery), and diffusion MRI (pre-surgery). We investigated pre-operative structure-function coupling at two spatial scales a) at the global iEEG network level and b) at the resolution of individual iEEG electrode contacts using virtual surgeries. At global network level, seizure-free individuals had stronger structure-function coupling pre-operatively than those that were not seizure-free regardless of the choice of interictal segment or frequency band. At the resolution of individual iEEG contacts, the virtual surgery approach provided complementary information to localize epileptogenic tissues. In predicting seizure outcomes, structure-function coupling measures were more important than clinical attributes, and together they predicted seizure outcomes with an accuracy of 85% and sensitivity of 87%. The underlying assumption that the structural changes induced by surgery translate to the functional level to control seizures is valid when the structure-functional coupling is strong. Mapping the regions that contribute to structure-functional coupling using virtual surgeries may help aid surgical planning.

q-bio.NC

Normative brain mapping of interictal intracranial EEG to localise epileptogenic tissue

The identification of abnormal electrographic activity is important in a wide range of neurological disorders, including epilepsy for localising epileptogenic tissue. However, this identification may be challenging during non-seizure (interictal) periods, especially if abnormalities are subtle compared to the repertoire of possible healthy brain dynamics. Here, we investigate if such interictal abnormalities become more salient by quantitatively accounting for the range of healthy brain dynamics in a location-specific manner. To this end, we constructed a normative map of brain dynamics, in terms of relative band power, from interictal intracranial recordings from 234 subjects (21,598 electrode contacts). We then compared interictal recordings from 62 patients with epilepsy to the normative map to identify abnormal regions. We hypothesised that if the most abnormal regions were spared by surgery, then patients would be more likely to experience continued seizures post-operatively. We first confirmed that the spatial variations of band power in the normative map across brain regions were consistent with healthy variations reported in the literature. Second, when accounting for the normative variations, regions which were spared by surgery were more abnormal than those resected only in patients with persistent post-operative seizures (t=-3.6, p=0.0003), confirming our hypothesis. Third, we found that this effect discriminated patient outcomes (AUC=0.75 p=0.0003). Normative mapping is a well-established practice in neuroscientific research. Our study suggests that this approach is feasible to detect interictal abnormalities in intracranial EEG, and of potential clinical value to identify pathological tissue in epilepsy. Finally, we make our normative intracranial map publicly available to facilitate future investigations in epilepsy and beyond.

q-bio.NC

Seizure pathways and seizure durations can vary independently within individual patients with focal epilepsy

A seizure's electrographic dynamics are characterised by its spatiotemporal evolution, also termed dynamical "pathway" and the time it takes to complete that pathway, which results in the seizure's duration. Both seizure pathways and durations can vary within the same patient, producing seizures with different dynamics, severity, and clinical implications. However, it is unclear whether seizures following the same pathway will have the same duration or if these features can vary independently. We compared within-subject variability in these seizure features using 1) epilepsy monitoring unit intracranial EEG (iEEG) recordings of 31 patients (mean 6.7 days, 16.5 seizures/subject), 2) NeuroVista chronic iEEG recordings of 10 patients (mean 521.2 days, 252.6 seizures/subject), and 3) chronic iEEG recordings of 3 dogs with focal-onset seizures (mean 324.4 days, 62.3 seizures/subject). While the strength of the relationship between seizure pathways and durations was highly subject-specific, in most subjects, changes in seizure pathways were only weakly to moderately associated with differences in seizure durations. The relationship between seizure pathways and durations was weakened by seizures that 1) had a common pathway, but different durations ("elastic pathways"), or 2) had similar durations, but followed different pathways ("duplicate durations"). Even in subjects with distinct populations of short and long seizures, seizure durations were not a reliable indicator of different seizure pathways. These findings suggest that seizure pathways and durations are modulated by different processes. Uncovering such modulators may reveal novel therapeutic targets for reducing seizure duration and severity.

q-bio.NC

Transfer Learning of Deep Spatiotemporal Networks to Model Arbitrarily Long Videos of Seizures

Detailed analysis of seizure semiology, the symptoms and signs which occur during a seizure, is critical for management of epilepsy patients. Inter-rater reliability using qualitative visual analysis is often poor for semiological features. Therefore, automatic and quantitative analysis of video-recorded seizures is needed for objective assessment. We present GESTURES, a novel architecture combining convolutional neural networks (CNNs) and recurrent neural networks (RNNs) to learn deep representations of arbitrarily long videos of epileptic seizures. We use a spatiotemporal CNN (STCNN) pre-trained on large human action recognition (HAR) datasets to extract features from short snippets (approx. 0.5 s) sampled from seizure videos. We then train an RNN to learn seizure-level representations from the sequence of features. We curated a dataset of seizure videos from 68 patients and evaluated GESTURES on its ability to classify seizures into focal onset seizures (FOSs) (N = 106) vs. focal to bilateral tonic-clonic seizures (TCSs) (N = 77), obtaining an accuracy of 98.9% using bidirectional long short-term memory (BLSTM) units. We demonstrate that an STCNN trained on a HAR dataset can be used in combination with an RNN to accurately represent arbitrarily long videos of seizures. GESTURES can provide accurate seizure classification by modeling sequences of semiologies.

cs.CV